Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review

Abstract Objective To determine the effect of polymorphisms and mutations in angiotensin-converting enzyme 2 (ACE2) and Type 2 transmembrane serine proteases (TMPRSS2) genes on susceptibility to corona virus disease 2019 (COVID-19) and patient prognosis. Introduction From December 2019 to the curren...

Full description

Bibliographic Details
Main Authors: Jingwei Li, Yali Wang, Yong Liu, Ziqu Zhang, Yuyun Zhai, Yan Dai, Zijian Wu, Xiang Nie, Lunfei Du
Format: Article
Language:English
Published: BMC 2022-02-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-022-00647-6
_version_ 1818501339001389056
author Jingwei Li
Yali Wang
Yong Liu
Ziqu Zhang
Yuyun Zhai
Yan Dai
Zijian Wu
Xiang Nie
Lunfei Du
author_facet Jingwei Li
Yali Wang
Yong Liu
Ziqu Zhang
Yuyun Zhai
Yan Dai
Zijian Wu
Xiang Nie
Lunfei Du
author_sort Jingwei Li
collection DOAJ
description Abstract Objective To determine the effect of polymorphisms and mutations in angiotensin-converting enzyme 2 (ACE2) and Type 2 transmembrane serine proteases (TMPRSS2) genes on susceptibility to corona virus disease 2019 (COVID-19) and patient prognosis. Introduction From December 2019 to the current time, an outbreak of epidemic of COVID-19, characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has occurred around the world. It is now clear that SARS-CoV-2 binds to human ACE2 receptors, with expression of these receptors correlated with the rate of SARS-CoV-2 infection and mortality. Polymorphisms in individual patient factors, such as ACE2 and TMPRSS2 genes have been linked with an increase in negative outcomes, although evidence to affirm remains debatable. Methods Here, we performed a systematic review, based on guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria, with the aim of assessing whether polymorphisms in ACE2 and TMPRSS2 genes affect the COVID-19 condition. We extensively searched PubMed, MEDLINE, Embase, the Cochrane Library, and Web of Science databases, for relevant articles and reports published in English between December 2019 and December 2021. Results A total of 495 full-text articles were downloaded, of which 185 were excluded after preliminary examination as they were duplicates. Finally, 310 articles were evaluated, by reading their titles and abstracts, and 208 of them eliminated based on our selection criteria. Finally, 33 articles met our inclusion criteria and were included in the final assessment. Genetic data from 33,923 patients with COVID-19 drawn from the general population and deriving from over 160 regions and 50 countries, as well as approximately 560,000 samples from global-public genetic databases, were included in our analysis. Ultimately, we identified 10 SNPs and 21 mutations in the ACE2 gene, along with 13 SNPs and 12 variants in the TMPRSS2 gene, which may be associated with COVID-19. Conclusions ACE2 and TMPRSS2 play vital roles in the onset, development, and prognosis of SARS-CoV-2 infection, and have both been strongly associated with vulnerability, intensity, and the clinical result of COVID-19. Overall, these genetic factors may have potential for future development of personalized drugs and vaccines against COVID-19. Trial registration: CRD42021239400 in PROSPERO 2021.
first_indexed 2024-12-10T20:54:47Z
format Article
id doaj.art-41b5e27146ba4add85198bbb7e2e3a75
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-12-10T20:54:47Z
publishDate 2022-02-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-41b5e27146ba4add85198bbb7e2e3a752022-12-22T01:34:00ZengBMCEuropean Journal of Medical Research2047-783X2022-02-0127111010.1186/s40001-022-00647-6Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic reviewJingwei Li0Yali Wang1Yong Liu2Ziqu Zhang3Yuyun Zhai4Yan Dai5Zijian Wu6Xiang Nie7Lunfei Du8Chengdu University of Traditional Chinese MedicineChengdu University of Traditional Chinese MedicineChengdu University of Traditional Chinese MedicineChengdu University of Traditional Chinese MedicineChengdu University of Traditional Chinese MedicineThe Third People’s Hospital of ZigongZigong Hospital of Traditional Chinese MedicineThe Third People’s Hospital of ZigongThe Third People’s Hospital of ZigongAbstract Objective To determine the effect of polymorphisms and mutations in angiotensin-converting enzyme 2 (ACE2) and Type 2 transmembrane serine proteases (TMPRSS2) genes on susceptibility to corona virus disease 2019 (COVID-19) and patient prognosis. Introduction From December 2019 to the current time, an outbreak of epidemic of COVID-19, characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has occurred around the world. It is now clear that SARS-CoV-2 binds to human ACE2 receptors, with expression of these receptors correlated with the rate of SARS-CoV-2 infection and mortality. Polymorphisms in individual patient factors, such as ACE2 and TMPRSS2 genes have been linked with an increase in negative outcomes, although evidence to affirm remains debatable. Methods Here, we performed a systematic review, based on guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria, with the aim of assessing whether polymorphisms in ACE2 and TMPRSS2 genes affect the COVID-19 condition. We extensively searched PubMed, MEDLINE, Embase, the Cochrane Library, and Web of Science databases, for relevant articles and reports published in English between December 2019 and December 2021. Results A total of 495 full-text articles were downloaded, of which 185 were excluded after preliminary examination as they were duplicates. Finally, 310 articles were evaluated, by reading their titles and abstracts, and 208 of them eliminated based on our selection criteria. Finally, 33 articles met our inclusion criteria and were included in the final assessment. Genetic data from 33,923 patients with COVID-19 drawn from the general population and deriving from over 160 regions and 50 countries, as well as approximately 560,000 samples from global-public genetic databases, were included in our analysis. Ultimately, we identified 10 SNPs and 21 mutations in the ACE2 gene, along with 13 SNPs and 12 variants in the TMPRSS2 gene, which may be associated with COVID-19. Conclusions ACE2 and TMPRSS2 play vital roles in the onset, development, and prognosis of SARS-CoV-2 infection, and have both been strongly associated with vulnerability, intensity, and the clinical result of COVID-19. Overall, these genetic factors may have potential for future development of personalized drugs and vaccines against COVID-19. Trial registration: CRD42021239400 in PROSPERO 2021.https://doi.org/10.1186/s40001-022-00647-6ACE2COVID-19Genetic susceptibilitySARS-CoV-2TMPRSS2
spellingShingle Jingwei Li
Yali Wang
Yong Liu
Ziqu Zhang
Yuyun Zhai
Yan Dai
Zijian Wu
Xiang Nie
Lunfei Du
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
European Journal of Medical Research
ACE2
COVID-19
Genetic susceptibility
SARS-CoV-2
TMPRSS2
title Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
title_full Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
title_fullStr Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
title_full_unstemmed Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
title_short Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
title_sort polymorphisms and mutations of ace2 and tmprss2 genes are associated with covid 19 a systematic review
topic ACE2
COVID-19
Genetic susceptibility
SARS-CoV-2
TMPRSS2
url https://doi.org/10.1186/s40001-022-00647-6
work_keys_str_mv AT jingweili polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview
AT yaliwang polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview
AT yongliu polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview
AT ziquzhang polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview
AT yuyunzhai polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview
AT yandai polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview
AT zijianwu polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview
AT xiangnie polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview
AT lunfeidu polymorphismsandmutationsoface2andtmprss2genesareassociatedwithcovid19asystematicreview